AIDS Healthcare Foundation at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

AIDS Healthcare Foundation brings 3 presentations to IDWeek 2026 in Washington, and exhibits at Booth 1443. Its program centres on long-acting HIV treatment and on syphilis therapy. One study reports high viral suppression and rare treatment failure with long-acting cabotegravir plus rilpivirine in real-world patients over several years.

Organization	IDWeek 2026 Attendance
AIDS Healthcare Foundation Los Angeles, CA
ahf.org Non-profits & societies Nonprofit providing HIV/AIDS medical care and advocacy to millions of people in about 50 countries, funded partly by its pharmacies and thrift stores.	Booth Exhibiting at Booth 1443 Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm Talk Fri Oct 23 11:05am–11:45am Part of Squabbles Among Friends: Pushing the Envelope on HIV Treatment and Prevention Making Long-acting Work in the Face of Questionable Resistance: To LEN or Not to LEN? 202 AB HIV-STD-TB · with University of California, San Francisco Antimicrobials, resistance and stewardship Talk Fri Oct 23 11:18am–11:30am Part of Late Breaking Abstracts: HIV & STDs Serologic Response Following Doxycycline Versus Benzathine Penicillin G for Syphilis Treatment: A Propensity Score-Matched Analysis 206 HIV, sexually transmitted infections and viral hepatitisAntimicrobials, resistance and stewardship Talk Fri Oct 23 2:21pm–2:33pm Part of Hot Off the Press: New Pathways in HIV Treatment High Suppression and Rare Virologic Failure with Long-Acting Cabotegravir + Rilpivirine: Real World Evidence Over Five Years from the OPERA Cohort 103 AB HIV, sexually transmitted infections and viral hepatitisAntimicrobials, resistance and stewardship

Organization

IDWeek 2026 Attendance

AIDS Healthcare Foundation

Los Angeles, CA

ahf.org

Non-profits & societies

Nonprofit providing HIV/AIDS medical care and advocacy to millions of people in about 50 countries, funded partly by its pharmacies and thrift stores.

Booth

Exhibiting at Booth 1443

Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm

Talk

Fri Oct 23
11:05am–11:45am

Part of Squabbles Among Friends: Pushing the Envelope on HIV Treatment and Prevention

Making Long-acting Work in the Face of Questionable Resistance: To LEN or Not to LEN?

202 AB

HIV-STD-TB · with University of California, San Francisco

Antimicrobials, resistance and stewardship

Talk

Fri Oct 23
11:18am–11:30am

Part of Late Breaking Abstracts: HIV & STDs

Serologic Response Following Doxycycline Versus Benzathine Penicillin G for Syphilis Treatment: A Propensity Score-Matched Analysis

206

HIV, sexually transmitted infections and viral hepatitisAntimicrobials, resistance and stewardship

Talk

Fri Oct 23
2:21pm–2:33pm

Part of Hot Off the Press: New Pathways in HIV Treatment

High Suppression and Rare Virologic Failure with Long-Acting Cabotegravir + Rilpivirine: Real World Evidence Over Five Years from the OPERA Cohort

103 AB

HIV, sexually transmitted infections and viral hepatitisAntimicrobials, resistance and stewardship

Instantly find 20 buyers from AIDS Healthcare Foundation

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction